Abpro Holdings (ABPO) Cash from Investing Activities (2022 - 2024)
Abpro Holdings' (ABPO) quarterly Cash from Investing Activities came in at -$20000.0 in Q3 2024, up 33.33% on a QoQ basis from -$30000.0 in Q2 2024.
Abpro Holdings (ABPO) Cash from Investing Activities (2022 - 2024) Analysis & Trends
Abpro Holdings (ABPO) has 3 years of Cash from Investing Activities data on file, last reported at -$20000.0 in Q3 2024.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$20000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $29.5 million (down 89.43% YoY) and the FY2023 annual result came in at $278.4 million, up 191.09% from the prior year.
- Cash from Investing Activities improved to -$20000.0 in Q3 2024, from -$30000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $278.6 million in Q2 2023 to a low of -$306.0 million in Q1 2022.
- A 3-year average of $344890.7 and a median of -$20000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities tumbled 148.26% — and 2024, when it tumbled 100.01%.
- Tracing ABPO's Cash from Investing Activities over 3 years: stood at $331516.0 in 2022, then plunged by 148.26% to -$160000.0 in 2023, then surged by 87.5% to -$20000.0 in 2024.
- The last three Cash from Investing Activities figures came in at -$20000.0 (Q3 2024), -$30000.0 (Q2 2024), and $29.7 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -20,000.00 |
| Sep 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | 29.69 Mn |
| Mar 31, 2024 | 29.69 Mn |
| Dec 31, 2023 | -160,000.00 |
| Dec 31, 2023 | -160,000.00 |
| Jun 30, 2023 | 278.60 Mn |
| Jun 30, 2023 | 278.60 Mn |
| Dec 31, 2022 | 331,516.00 |
| Dec 31, 2022 | 331,516.00 |
| Mar 31, 2022 | -306.00 Mn |
| Mar 31, 2022 | -306.00 Mn |